Boothbay Fund Management, LLC Edgewise Therapeutics, Inc. Transaction History
Boothbay Fund Management, LLC
- $3.28 Billion
- Q1 2025
A detailed history of Boothbay Fund Management, LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 85,214 shares of EWTX stock, worth $1.14 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
85,214Holding current value
$1.14 Million% of portfolio
0.06%Shares
3 transactions
Others Institutions Holding EWTX
# of Institutions
217Shares Held
109MCall Options Held
2.5MPut Options Held
1.28M-
Orbimed Advisors LLC San Diego, CA15MShares$201 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$119 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$87.7 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$82.4 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$80.6 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $846M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...